Aberrant promoter hypermethylation inhibits RGMA expression and contributes to tumor progression in breast cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

Darshan S. Chandrashekar, Bhuwan Bashel, Sai Akshaya Hodigere Balasubramanya et al. · Neoplasia · 2017 · 6.5K citations · Full text

Life Sciences, Molecular Biology, Oncology +17

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Balázs Győrffy, András Lánczky, Aron C. Eklund et al. · Breast Cancer Research and Treatment · 2009 · 4.3K citations

Medicine, Bioinformatics, Oncology +15

DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis

Rajneesh Pathania, Sabarish Ramachandran, Selvakumar Elangovan et al. · Nature Communications · 2015 · 261 citations · Full text

Medicine, Molecular Biology, Oncology +17

Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis

Hao Liu, Ying Song, Huishi Qiu et al. · Cell Death and Differentiation · 2019 · 258 citations · Full text

Medicine, Genetics, Oncology +17